Treatment Of Liver Fibrosis With Antibodies Against Alpha V Beta 6 Integrin


The full document isn't yet available to us from the patent office.


The invention provides the use of an antibody that specifically binds to alpha v beta 6 and blocks binding of a ligand to alpha v beta 6 for the manufacture of a medicament for treating liver fibrosis in a patient.


Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Feb 9, 2005
  • Application: Aug 7, 1998
    EP EP 04022921 A
  • Priority: Aug 7, 1998
    EP EP 98939278 A
  • Priority: Aug 8, 1997
    US US 5506097 P

Sign in to the Lens